OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-18.45%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$313M
AUM Growth
+$313M
Cap. Flow
-$49.9M
Cap. Flow %
-15.93%
Top 10 Hldgs %
88.94%
Holding
23
New
1
Increased
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$81.7M 26.07% 4,673,380
NUVB icon
2
Nuvation Bio
NUVB
$1.02B
$49.4M 15.77% 15,247,340 -7,710,000 -34% -$25M
IMGO
3
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$40.4M 12.9% 3,018,737
MORF
4
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$21.9M 7% 1,010,769 -189,245 -16% -$4.11M
CINC
5
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$18.2M 5.81% 966,176
ALPN
6
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$17.3M 5.51% 2,029,580
KRON
7
DELISTED
Kronos Bio
KRON
$13.9M 4.44% 3,818,283
ARQT icon
8
Arcutis Biotherapeutics
ARQT
$1.86B
$13.3M 4.24% 623,836
GOSS icon
9
Gossamer Bio
GOSS
$562M
$12.6M 4.01% 1,500,000 -1,664,835 -53% -$13.9M
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
$9.96M 3.18% 2,249,123
IMUX icon
11
Immunic
IMUX
$80.9M
$6.21M 1.98% 1,788,160
SANA icon
12
Sana Biotechnology
SANA
$777M
$5.43M 1.73% 843,750
OMEG
13
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$4.94M 1.58% 501,000
THRX
14
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.93M 1.26% 711,479
PRTK
15
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.8M 1.21% 1,971,241
SPRB
16
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$3.76M 1.2% 2,161,022
SYRS
17
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.42M 0.77% 2,512,705
IMCR icon
18
Immunocore
IMCR
$1.62B
$1.92M 0.61% 51,535
EPIX icon
19
ESSA Pharma
EPIX
$11.4M
$1.03M 0.33% 328,196
JNCE
20
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$835K 0.27% 275,513
SNTI icon
21
Senti Biosciences
SNTI
$38.5M
$386K 0.12% +195,792 New +$386K
ICVX
22
DELISTED
Icosavax, Inc. Common Stock
ICVX
-426,395 Closed -$3M
CMPI
23
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
-1,335,050 Closed -$4.26M